Literature DB >> 18272470

Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.

Jennifer A Ronesi1, Kimberly M Huber.   

Abstract

Fragile X syndrome (FXS) mental retardation is caused by loss-of-function mutations in an RNA-binding protein, fragile X mental retardation protein (FMRP). Previous studies in patients or animal models of FXS have identified alterations in dendritic spine structure, as well as synaptic plasticity induced by metabotropic glutamate receptors (mGluRs). The translation of multiple messenger RNA (mRNA) targets of FMRP is regulated by mGluRs at synapses. Here, we incorporate data from several studies into a working model of how FMRP regulates mGluR-stimulated protein synthesis and, in turn, regulates protein synthesis-dependent synaptic plasticity. Understanding the complex functions of FMRP at the synapse will lead to a better understanding of the neurobiological underpinnings of mental retardation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272470     DOI: 10.1126/stke.15pe6

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  56 in total

1.  Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization.

Authors:  Hansen Wang; Susan S Kim; Min Zhuo
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome.

Authors:  Aparna Suvrathan; Charles A Hoeffer; Helen Wong; Eric Klann; Sumantra Chattarji
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

3.  Delayed stabilization of dendritic spines in fragile X mice.

Authors:  Alberto Cruz-Martín; Michelle Crespo; Carlos Portera-Cailliau
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 4.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 5.  The trouble with spines in fragile X syndrome: density, maturity and plasticity.

Authors:  C X He; C Portera-Cailliau
Journal:  Neuroscience       Date:  2012-04-20       Impact factor: 3.590

6.  Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment.

Authors:  Catherine H Choi; Brian P Schoenfeld; Aaron J Bell; Paul Hinchey; Maria Kollaros; Michael J Gertner; Newton H Woo; Michael R Tranfaglia; Mark F Bear; R Suzanne Zukin; Thomas V McDonald; Thomas A Jongens; Sean M J McBride
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

Review 7.  The state of synapses in fragile X syndrome.

Authors:  Brad E Pfeiffer; Kimberly M Huber
Journal:  Neuroscientist       Date:  2009-03-26       Impact factor: 7.519

Review 8.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

9.  The fragile X mental retardation protein: a valuable partner in the battle against epileptogenesis.

Authors:  Lisa R Merlin
Journal:  Epilepsy Curr       Date:  2009 Jul-Aug       Impact factor: 7.500

10.  Dendritic mRNA targeting of Jacob and N-methyl-d-aspartate-induced nuclear translocation after calpain-mediated proteolysis.

Authors:  Stefan Kindler; Daniela C Dieterich; Janin Schütt; Jale Sahin; Anna Karpova; Marina Mikhaylova; Claudia Schob; Eckart D Gundelfinger; Hans-Jürgen Kreienkamp; Michael R Kreutz
Journal:  J Biol Chem       Date:  2009-07-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.